Search
Adaptive Biotechnologies Corp
ADPTAdd to Watchlist
27.980USD
+1.150+4.29%
Close 11-06 16:00（ET）
4.47BMarket Cap
LossP/E TTM
After-hours 17:18 (ET)27.510USD-0.490-1.75%
After-hours 17:18 (ET)Today
+4.29%
5 Days
+5.03%
1 Month
+4.01%
6 Months
+93.90%
Year to Date
+72.29%
1 Year
+79.82%
Key Figures
26.980Open
28.273High
631.99KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.40%Turnover Ratio
26.830Prev. Close
26.540Low
17.39MTurnover
LossP/E Static
25.32P/B
0.00%Div Yield TTM
-9.76%ROA
30.74052wk High
85.43Volume Ratio
-159.49MNet Profit
159.60MShares
-0.3209EPS TTM
2.16Beta
-24.43%ROE
12.00052wk Low
10.18%Amplitude
73.46%Gross Margin
4.47BMarket Cap
3.36Reward/Risk
4.18%Risk Rate
Adaptive Biotechnologies Corp's Score
0.01vs previous score
Forecast8.44
Financial Health7.79
Technical4.32
Valuation Dimensions9.77
Institutional Confidence10.00
Risk Assessment5.94
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Adaptive Biotechnologies Corp Technical Analysis
Technical Indicators
Buy
Summary
Buy
Moving Average
Strong buy
Adaptive Biotechnologies Corp Latest Earnings Call Transcripts
Adaptive Biotechnologies (ADPT) Q3 2026 Earnings Call: MRD Guidance Raised
Adaptive Biotechnologies Q3 2026 revenue rose 39% to $83.9 million as MRD growth drove profitability and a higher $276 million–$286 million outlook.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
0.02/-0.10
Revenue / Forecast
83.90M/71.60M
Adaptive Biotechnologies Corp Profile
SectorBiotechnology & Medical Research
Ticker SymbolADPT
Number of employees619
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Viking Global Investors LP | 18.74% |
| BlackRock Institutional Trust Company, N.A. | 6.92% |
| Vanguard Capital Management, LLC | 3.81% |
| Westfield Capital Management Company, L.P. | 3.40% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor/Hedge Fund | 46.81% |
| Investment Advisor | 40.11% |
| Hedge Fund | 5.05% |
| Individual Investor | 2.10% |
Related Instruments
-0.79%
+1.43%
+1.07%
-0.14%
+0.38%
-0.22%
+0.03%
-0.41%
+0.02%
-0.20%
+0.85%
-1.57%
-1.04%
+0.28%
+5.27%
-0.16%
+0.16%
-0.80%
+1.46%
+3.63%Popular Instruments
51290.600
-208.500 (-0.41%)
26964.500
+329.300 (+1.24%)
7380.000
+23.100 (+0.31%)
12797.000
-1.000 (-0.01%)
58142.000
+876.000 (+1.53%)
6140.600
-37.200 (-0.60%)
89.857
-0.176 (-0.20%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4065.670
-33.020 (-0.81%)
FAQs
What is the current price of Adaptive Biotechnologies Corp (ADPT)?
The current price of Adaptive Biotechnologies Corp (ADPT) is 27.98.
What is the symbol of Adaptive Biotechnologies Corp?
The ticker symbol of Adaptive Biotechnologies Corp is ADPT.
What is the 52-week high of Adaptive Biotechnologies Corp?
The 52-week high of Adaptive Biotechnologies Corp is 30.74.
What is the 52-week low of Adaptive Biotechnologies Corp?
The 52-week low of Adaptive Biotechnologies Corp is 12.00.
What is the market capitalization of Adaptive Biotechnologies Corp?
The market capitalization of Adaptive Biotechnologies Corp is 4.47B.
Is Adaptive Biotechnologies Corp (ADPT) currently rated as Buy, Hold, or Sell?
According to analysts, Adaptive Biotechnologies Corp (ADPT) has an overall rating of Buy, with a price target of 29.81.
What is the Earnings Per Share (EPS TTM) of Adaptive Biotechnologies Corp (ADPT)?
The Earnings Per Share (EPS TTM) of Adaptive Biotechnologies Corp (ADPT) is -0.32.